Five of 54 were disqualified at the screening visit due to inability to attend all scheduled study visits (n = 2), uncontrolled hypertension (n = 1), non-consent for biological samples (n = 1), and clinically significant alanine transferase (ALT) value (n = 1). This evidence concerns the gene GPT and Hypertension.